{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:16:03Z","timestamp":1783059363621,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T00:00:00Z","timestamp":1340323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00467-012-2223-8","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T22:03:02Z","timestamp":1340316182000},"page":"689-698","source":"Crossref","is-referenced-by-count":16,"title":["Histone deacetylases in kidney development: implications for disease and therapy"],"prefix":"10.1007","volume":"28","author":[{"given":"Shaowei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"El-Dahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,22]]},"reference":[{"key":"2223_CR1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrg2205","volume":"8","author":"A Schedl","year":"2007","unstructured":"Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8:791\u2013802","journal-title":"Nat Rev Genet"},{"key":"2223_CR2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/dvdy.21094","volume":"236","author":"JC Kiefer","year":"2007","unstructured":"Kiefer JC (2007) Epigenetics in development. Dev Dyn 236:1144\u20131156","journal-title":"Dev Dyn"},{"key":"2223_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.semnephrol.2009.03.009","volume":"29","author":"KJ Reidy","year":"2009","unstructured":"Reidy KJ, Rosenblum ND (2009) Cell and molecular biology of kidney development. Semin Nephrol 29:321\u2013337","journal-title":"Semin Nephrol"},{"key":"2223_CR4","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1242\/dev.034876","volume":"136","author":"GR Dressler","year":"2009","unstructured":"Dressler GR (2009) Advances in early kidney specification, development and patterning. Development 136:3863\u20133874","journal-title":"Development"},{"key":"2223_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/bies.20687","volume":"30","author":"CL Smith","year":"2008","unstructured":"Smith CL (2008) A shifting paradigm: histone deacetylases and transcriptional activation. BioEssays 30:15\u201324","journal-title":"BioEssays"},{"key":"2223_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJM Ruijter De","year":"2003","unstructured":"De Ruijter AJM, Van Gennip AH, Caron HN, Kemp S, Van Kuilenburg ABP (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737\u2013749","journal-title":"Biochem J"},{"key":"2223_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","volume":"363","author":"MA Glozak","year":"2005","unstructured":"Glozak MA, Sengupta N, Zhang XH, Seto E (2005) Acetylation and deacetylation of non-histone proteins. Gene 363:15\u201323","journal-title":"Gene"},{"key":"2223_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biocel.2008.08.027","volume":"41","author":"S Spange","year":"2009","unstructured":"Spange S, Wagner T, Heinzel T, Kramer OH (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. J Biochem Cell Biol 41:185\u2013198","journal-title":"J Biochem Cell Biol"},{"key":"2223_CR9","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/MCB.25.8.2873-2884.2005","volume":"25","author":"XJ Yang","year":"2005","unstructured":"Yang XJ, Gregoire S (2005) Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 25:2873\u20132884","journal-title":"Mol Cell Biol"},{"key":"2223_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.74.082803.133500","volume":"75","author":"AA Sauve","year":"2006","unstructured":"Sauve AA, Wolberger C, Schramm VL, Boeke JD (2006) The biochemistry of sirtuins. Annu Rev Biochem 75:435\u2013465","journal-title":"Annu Rev Biochem"},{"key":"2223_CR11","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1074\/jbc.M105993200","volume":"277","author":"WM Yang","year":"2002","unstructured":"Yang WM, Tsai SC, Wen YD, Fejer G, Seto E (2002) Functional domains of histone deacetylase-3. J Biol Chem 277:9447\u20139454","journal-title":"J Biol Chem"},{"key":"2223_CR12","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/sj.onc.1210612","volume":"26","author":"P Karagianni","year":"2007","unstructured":"Karagianni P, Wong J (2007) HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26:5439\u20135449","journal-title":"Oncogene"},{"key":"2223_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32\u201342","journal-title":"Nat Rev Genet"},{"key":"2223_CR14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2004.10.024","volume":"119","author":"RB Vega","year":"2004","unstructured":"Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555\u2013566","journal-title":"Cell"},{"key":"2223_CR15","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","volume":"24","author":"S Chang","year":"2004","unstructured":"Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA, Olson EN (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24:8467\u20138476","journal-title":"Mol Cell Biol"},{"key":"2223_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","volume":"110","author":"CL Zhang","year":"2002","unstructured":"Zhang CL, McKinsey TA, Chang SR, Antos CL, Hill JA, Olson EN (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479\u2013488","journal-title":"Cell"},{"key":"2223_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","volume":"126","author":"S Chang","year":"2006","unstructured":"Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126:321\u2013334","journal-title":"Cell"},{"key":"2223_CR18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1093\/nar\/29.13.2836","volume":"29","author":"SJ Choi","year":"2001","unstructured":"Choi SJ, Park SY, Han TH (2001) 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation. Nucleic Acids Res 29:2836\u20132842","journal-title":"Nucleic Acids Res"},{"key":"2223_CR19","doi-asserted-by":"crossref","first-page":"17007","DOI":"10.1074\/jbc.M101508200","volume":"276","author":"U Dressel","year":"2001","unstructured":"Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, Muscat GE (2001) A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem 276:17007\u201317013","journal-title":"J Biol Chem"},{"key":"2223_CR20","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/MCB.00189-08","volume":"28","author":"MS Kim","year":"2008","unstructured":"Kim MS, Fielitz J, McAnally J, Shelton JM, Lemon DD, McKinsey TA, Richardson JA, Bassel-Duby R, Olson EN (2008) Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance. Mol Cell Biol 28:3600\u20133609","journal-title":"Mol Cell Biol"},{"key":"2223_CR21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35040593","volume":"408","author":"TA McKinsey","year":"2000","unstructured":"McKinsey TA, Zhang CL, Lu J, Olson EN (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106\u2013111","journal-title":"Nature"},{"key":"2223_CR22","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","volume":"96","author":"CM Grozinger","year":"1999","unstructured":"Grozinger CM, Hassig CA, Schreiber SL (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96:4868\u20134873","journal-title":"Proc Natl Acad Sci USA"},{"key":"2223_CR23","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1074\/jbc.274.4.2440","volume":"274","author":"A Verdel","year":"1999","unstructured":"Verdel A, Khochbin S (1999) Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J Biol Chem 274:2440\u20132445","journal-title":"J Biol Chem"},{"key":"2223_CR24","doi-asserted-by":"crossref","first-page":"25748","DOI":"10.1074\/jbc.M111871200","volume":"277","author":"L Gao","year":"2002","unstructured":"Gao L, Cueto MA, Asselbergs F, Atadja P (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277:25748\u201325755","journal-title":"J Biol Chem"},{"key":"2223_CR25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jnr.21521","volume":"86","author":"H Liu","year":"2008","unstructured":"Liu H, Hu Q, Kaufman A, D\u2019Ercole AJ, Ye P (2008) Developmental expression of histone deacetylase 11 in the murine brain. J Neurosci Res 86:537\u2013543","journal-title":"J Neurosci Res"},{"key":"2223_CR26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.2007101078","volume":"19","author":"AP McMahon","year":"2008","unstructured":"McMahon AP, Aronow BJ, Davidson DR, Davies JA, Gaido KW, Grimmond S, Lessard JL, Little MH, Potter SS, Wilder EL, Zhang P, Project G (2008) GUDMAP: the Genitourinary Developmental Molecular Anatomy Project. J Am Soc Nephrol 19:667\u2013671","journal-title":"J Am Soc Nephrol"},{"key":"2223_CR27","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M111.248278","volume":"286","author":"S Chen","year":"2011","unstructured":"Chen S, Bellew C, Yao X, Stefkova J, Dipp S, Saifudeen Z, Bachvarov D, El-Dahr SS (2011) Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem 286:32775\u201332789","journal-title":"J Biol Chem"},{"key":"2223_CR28","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2165\/11315680-000000000-00000","volume":"69","author":"X Ma","year":"2009","unstructured":"Ma X, Ezzeldin HH, Diasio RB (2009) Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69:1911\u20131934","journal-title":"Drugs"},{"key":"2223_CR29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5:981\u2013989","journal-title":"Mol Cancer Res"},{"key":"2223_CR30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1681\/ASN.2009080851","volume":"21","author":"ED Groh de","year":"2010","unstructured":"de Groh ED, Swanhart LM, Cosentino CC, Jackson RL, Dai W, Kitchens CA, Day BW, Smithgall TE, Hukriede NA (2010) Inhibition of histone deacetylase expands the renal progenitor cell population. J Am Soc Nephrol 21:794\u2013802","journal-title":"J Am Soc Nephrol"},{"key":"2223_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1152\/physiolgenomics.2000.3.3.121","volume":"3","author":"SS El-Dahr","year":"2000","unstructured":"El-Dahr SS, Harrison-Bernard LM, Dipp S, Yosipiv IV, Meleg-Smith S (2000) Bradykinin B2 null mice are prone to renal dysplasia: gene\u2013environment interactions in kidney development. Physiol Genomics 3:121\u2013131","journal-title":"Physiol Genomics"},{"key":"2223_CR32","doi-asserted-by":"crossref","first-page":"F98","DOI":"10.1152\/ajprenal.00246.2004","volume":"288","author":"H Fan","year":"2005","unstructured":"Fan H, Harrell JR, Dipp S, Saifudeen Z, El-Dahr SS (2005) A novel pathological role of p53 in kidney development revealed by gene\u2013environment interactions. Am J Physiol Renal Physiol 288:F98\u2013F107","journal-title":"Am J Physiol Renal Physiol"},{"key":"2223_CR33","doi-asserted-by":"crossref","first-page":"F1404","DOI":"10.1152\/ajprenal.90378.2008","volume":"295","author":"SS El-Dahr","year":"2008","unstructured":"El-Dahr SS, Aboudehen K, Dipp S (2008) Bradykinin B2 receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis. Am J Physiol Renal Physiol 295:F1404\u2013F1413","journal-title":"Am J Physiol Renal Physiol"},{"key":"2223_CR34","doi-asserted-by":"crossref","first-page":"31234","DOI":"10.1074\/jbc.M606510200","volume":"281","author":"D Bodegom Van","year":"2006","unstructured":"Van Bodegom D, Saifudeen Z, Dipp S, Puri S, Magenheimer BS, Calvet JP, El-Dahr SS (2006) The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression. J Biol Chem 281:31234\u201331244","journal-title":"J Biol Chem"},{"key":"2223_CR35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","volume":"67","author":"AC Ong","year":"2005","unstructured":"Ong AC, Harris PC (2005) Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int 67:1234\u20131247","journal-title":"Kidney Int"},{"key":"2223_CR36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.2006111215","volume":"18","author":"BK Yoder","year":"2007","unstructured":"Yoder BK (2007) Role of primary cilia in the pathogenesis of polycystic kidney disease. J Am Soc Nephrol 18:1381\u20131388","journal-title":"J Am Soc Nephrol"},{"key":"2223_CR37","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1073\/pnas.0911987106","volume":"106","author":"Y Cao","year":"2009","unstructured":"Cao Y, Semanchik N, Lee SH, Somlo S, Barbano PE, Coifman R, Sun Z (2009) Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci USA 106:21819\u201321824","journal-title":"Proc Natl Acad Sci USA"},{"key":"2223_CR38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dev.049437","volume":"137","author":"S Xia","year":"2010","unstructured":"Xia S, Li X, Johnson T, Seidel C, Wallace DP, Li R (2010) Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts. Development 137:1075\u20131084","journal-title":"Development"},{"key":"2223_CR39","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","volume":"21","author":"G Lagger","year":"2002","unstructured":"Lagger G, O\u2019Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C (2002) Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21:2672\u20132681","journal-title":"EMBO J"},{"key":"2223_CR40","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","volume":"21","author":"RL Montgomery","year":"2007","unstructured":"Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN (2007) Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21:1790\u20131802","journal-title":"Genes Dev"},{"key":"2223_CR41","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.4049\/jimmunol.0903610","volume":"185","author":"R Grausenburger","year":"2010","unstructured":"Grausenburger R, Bilic I, Boucheron N, Zupkovitz G, El-Housseiny L, Tschismarov R, Zhang Y, Rembold M, Gaisberger M, Hartl A, Epstein MM, Matthias P, Seiser C, Ellmeier W (2010) Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J Immunol 185:3489\u20133497","journal-title":"J Immunol"},{"key":"2223_CR42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1552","volume":"13","author":"CM Trivedi","year":"2007","unstructured":"Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA (2007) Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 13:324\u2013331","journal-title":"Nat Med"},{"key":"2223_CR43","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1158\/0008-5472.CAN-07-0312","volume":"67","author":"S Zimmermann","year":"2007","unstructured":"Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, Floss T, Wurst W, Minucci S, Gottlicher M (2007) Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res 67:9047\u20139054","journal-title":"Cancer Res"},{"key":"2223_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55\u201360","journal-title":"Nature"},{"key":"2223_CR45","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","volume":"118","author":"RL Montgomery","year":"2008","unstructured":"Montgomery RL, Potthoff MJ, Haberland M, Qi X, Matsuzaki S, Humphries KM, Richardson JA, Bassel-Duby R, Olson EN (2008) Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J Clin Invest 118:3588\u20133597","journal-title":"J Clin Invest"},{"key":"2223_CR46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ccr.2010.10.022","volume":"18","author":"S Bhaskara","year":"2010","unstructured":"Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S, Yenamandra A, Locke K, Yuan JL, Bonine-Summers AR, Wells CE, Kaiser JF, Washington MK, Zhao Z, Wagner FF, Sun ZW, Xia F, Holson EB, Khabele D, Hiebert SW (2010) Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 18:436\u2013447","journal-title":"Cancer Cell"},{"key":"2223_CR47","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.1809209","volume":"23","author":"M Haberland","year":"2009","unstructured":"Haberland M, Mokalled MH, Montgomery RL, Olson EN (2009) Epigenetic control of skull morphogenesis by histone deacetylase 8. Genes Dev 23:1625\u20131630","journal-title":"Genes Dev"},{"key":"2223_CR48","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","volume":"28","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Kwon S, Yamaguchi T, Cubizolles F, Rousseaux S, Kneissel M, Cao C, Li N, Cheng HL, Chua K, Lombard D, Mizeracki A, Matthias G, Alt FW, Khochbin S, Matthias P (2008) Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 28:1688\u20131701","journal-title":"Mol Cell Biol"},{"key":"2223_CR49","doi-asserted-by":"crossref","unstructured":"Reichert N, Choukrallah MA, Matthias P (2012) Multiple roles of class I HDACs in proliferation, differentiation, and development. Cell Mol Life Sci. doi: 10.1007\/s00018-012-0921-9","DOI":"10.1007\/s00018-012-0921-9"},{"key":"2223_CR50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.devcel.2010.10.015","volume":"19","author":"M LeBoeuf","year":"2010","unstructured":"LeBoeuf M, Terrell A, Trivedi S, Sinha S, Epstein JA, Olson EN, Morrisey EE, Millar SE (2010) Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell 19:807\u2013818","journal-title":"Dev Cell"},{"key":"2223_CR51","doi-asserted-by":"crossref","first-page":"E481","DOI":"10.1073\/pnas.1118403109","volume":"109","author":"P Ma","year":"2012","unstructured":"Ma P, Pan H, Montgomery RL, Olson EN, Schultz RM (2012) Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. Proc Natl Acad Sci USA 109:E481\u2013E489","journal-title":"Proc Natl Acad Sci USA"},{"key":"2223_CR52","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1093\/emboj\/cdf616","volume":"21","author":"A Ito","year":"2002","unstructured":"Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, Yao TP (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21:6236\u20136245","journal-title":"EMBO J"},{"key":"2223_CR53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ydbio.2011.03.017","volume":"353","author":"S Hilliard","year":"2011","unstructured":"Hilliard S, Aboudehen K, Yao X, El-Dahr SS (2011) Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching. Dev Biol 353:354\u2013366","journal-title":"Dev Biol"},{"issue":"Suppl 1","key":"2223_CR54","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2011.0124","volume":"9","author":"GR Hudes","year":"2011","unstructured":"Hudes GR, Carducci MA, Choueiri TK, Esper P, Jonasch E, Kumar R, Margolin KA, Michaelson MD, Motzer RJ, Pili R, Roethke S, Srinivas S (2011) NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. J Nat Compr Cancer Netw 9(Suppl 1):S1\u2013S29","journal-title":"J Nat Compr Cancer Netw"},{"key":"2223_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/2006-00005.Dinarello","volume":"11","author":"F Leoni","year":"2005","unstructured":"Leoni F, Fossati G, Lewis EC, Lee JK, Porro G, Pagani P, Modena D, Moras ML, Pozzi P, Reznikov LL, Siegmund B, Fantuzzi G, Dinarello CA, Mascagni P (2005) The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med 11:1\u201315","journal-title":"Mol Med"},{"key":"2223_CR56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","volume":"366","author":"G Lehrman","year":"2005","unstructured":"Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM (2005) Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366:549\u2013555","journal-title":"Lancet"},{"key":"2223_CR57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2222.2004.02006.x","volume":"35","author":"JH Choi","year":"2005","unstructured":"Choi JH, Oh SW, Kang MS, Kwon HJ, Oh GT, Kim DY (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35:89\u201396","journal-title":"Clin Exp Allergy"},{"key":"2223_CR58","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","volume":"113","author":"Y Kong","year":"2006","unstructured":"Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:2579\u20132588","journal-title":"Circulation"},{"key":"2223_CR59","doi-asserted-by":"crossref","first-page":"28930","DOI":"10.1074\/jbc.M303113200","volume":"278","author":"CL Antos","year":"2003","unstructured":"Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, Rindt H, Gorczynski RJ, Olson EN (2003) Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278:28930\u201328937","journal-title":"J Biol Chem"},{"key":"2223_CR60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3747\/co.v15i5.371","volume":"15","author":"DR Walkinshaw","year":"2008","unstructured":"Walkinshaw DR, Yang XJ (2008) Histone deacetylase inhibitors as novel anticancer therapeutics. Curr Oncol 15:237\u2013243","journal-title":"Curr Oncol"},{"key":"2223_CR61","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jcb.21746","volume":"104","author":"DR Walkinshaw","year":"2008","unstructured":"Walkinshaw DR, Tahmasebi S, Bertos NR, Yang XJ (2008) Histone deacetylases as transducers and targets of nuclear signaling. J Cell Biochem 104:1541\u20131552","journal-title":"J Cell Biochem"},{"key":"2223_CR62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2404464","volume":"21","author":"TC Karagiannis","year":"2007","unstructured":"Karagiannis TC, El-Osta A (2007) Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds? Leukemia 21:61\u201365","journal-title":"Leukemia"},{"key":"2223_CR63","first-page":"718","volume":"8","author":"V Sandor","year":"2002","unstructured":"Sandor V, Bakke S, Robey RW, Kang MH, Blagosklonny MV, Bender J, Brooks R, Piekarz RL, Tucker E, Figg WD, Chan KK, Goldspiel B, Fojo AT, Balcerzak SP, Bates SE (2002) Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 8:718\u2013728","journal-title":"Clin Cancer Res"},{"key":"2223_CR64","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1200\/JCO.2005.02.188","volume":"23","author":"QC Ryan","year":"2005","unstructured":"Ryan QC, Headlee D, Acharya M, Sparreboom A, Trepel JB, Ye J, Figg WD, Hwang K, Chung EJ, Murgo A, Melillo G, Elsayed Y, Monga M, Kalnitskiy M, Zwiebel J, Sausville EA (2005) Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol 23:3912\u20133922","journal-title":"J Clin Oncol"},{"key":"2223_CR65","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood-2011-10-387365","volume":"119","author":"L Santo","year":"2012","unstructured":"Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N (2012) Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. Blood 119:2579\u20132589","journal-title":"Blood"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2223-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2223-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2223-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T07:52:32Z","timestamp":1642578752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2223-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,22]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2223"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2223-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,22]]}}}